Page 372

for numerous neurological journals and on advisory boards for such organizations as the National Multiple Sclerosis Society, the American Neurological Association, and the Multiple Sclerosis Society of Canada. Prior to his work at McGill, Dr. Antel was Professor of Neurology at the University of Chicago. His interests include interactions between the immune and central nervous systems and inflammatory demyelinating disorders, including multiple sclerosis.

Samuel Broder is the Executive Vice President of Celera Genomics, whose mission it is to become the definitive source of genomic and information. He is the former director of the National Cancer Institute at NIH and worked there for 23 years as an investigator and administrator. Dr. Broder is a Fellow of the American College of Physicians, a member of the Institute of Medicine, American Society for Clinical Investigation, Association of American Physicians, American Association of Immunologists, and the Clinical Immunology Society and serves on the editorial advisory boards of numerous journals. His expertise includes research management in government and industry, the development of anti-retroviral drugs, and cancer biology. Dr. Broder served on the IOM Forum on Drug Development.

Jesse M. Cedarbaum is Vice President of Clinical Affairs at Regeneron Pharmaceuticals, Inc., and Clinical Associate Professor of Neurology at Mount Sinai Medical School. His expertise includes clinical research, biostatistics, regulatory affairs, clinical pharmacology and pharmacokinetics and toxicology. His areas of clinical research interests and activities have included Parkinson's disease, amyotrophic lateral sclerosis, peripheral neuropathy, and retinal degenerative disorders. Prior to joining Regeneron in 1990, Dr. Cedarbaum was Director of the Parkinson's Disease and Movement Disorder program at New York Hospital-Cornell Medical Center in New York, and the Burke Rehabilitation Center in White Plains, NY, and Associate Clinical Professor of Neurology at Cornell Medical School from 1983 to 1990. Dr. Cedarbaum received his B.A. and M.A. from Stanford University and his M.D. from Yale Medical School.

Patricia K. Coyle is Professor of Neurology and Director of the Stony Brook Multiple Sclerosis Comprehensive Care Center at SUNY Stony Brook. Her areas of expertise include neurologic infectious disease, in particular Lyme disease and multiple sclerosis. She is actively engaged in multiple sclerosis therapeutic trials and studies to elucidate neurologic Lyme disease. She is a member of many committees of the American Academy of Neurology, American Neurological Association and National Multiple Sclerosis Society, and has been an expert adviser to the Food and Drug Administration.

Stephen L. Hauser has served as Chairman and Betty Anker Fife Professor of Department of Neurology at the University of California, San Francisco since



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement